Fundz

Encoded Therapeutics raises $275 million in Series F financing to advance ETX101 through pivotal development and accelerate its precision genetic medicines neurology pipeline.

PRIVATESep 09, 2026

Amount Raised

$275 Million

Round Type

Series F

South San FranciscoBiotechnologyHealth CareTherapeutics

Investors

Softbank Vision FundRTW InvestmentsJanus HendersonGV

Description

Encoded Therapeutics has successfully raised $275 million in its Series F financing round. The funds will be utilized to advance its lead product, ETX101, and accelerate the development of its precision genetic medicines for neurology. This financing is a significant step forward in the company's mission to deliver innovative treatments. The investment showcases strong confidence in the company's pipeline and growth potential.

Who to call at Encoded Therapeutics, and when

A new round usually means Encoded Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Encoded Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Encoded Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Encoded Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Encoded Therapeutics

Location

South San Francisco, California, United States

About

Encoded Therapeutics is a clinical-stage biotechnology company focused on developing genetic medicines for severe central nervous system (CNS) disorders. They specialize in creating potentially disease-modifying therapies that aim to improve the lives of individuals affected by these challenging conditions. The company's proprietary vector engineering approach integrates novel regulatory elements and payloads with AAV vectors. Their flagship clinical program, ETX101, targets the underlying causes of Dravet syndrome.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Encoded Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Encoded Therapeutics's next move

See what Strategic adds

Encoded Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.